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Edited by Vladimir SkulachevAbstract Glycodelin A (GdA), a dimeric lipocalin, expressed by
the uterine endometrium, is an immunomodulatory agent and in-
duces apoptosis in T-cells. In this study we demonstrate that two
populations of GdA with subtle diﬀerences in their net ionic
charge are present in the amniotic ﬂuid and that, apoptotic activ-
ity is exhibited only by the population with more sialic acid res-
idues. Signiﬁcantly, removal of sialic acid residues from the
active populations of GdA abrogates the activity of the molecule,
suggesting that the extent of sialylation might be a factor regu-
lating the activity of GdA.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Glycodelin (Gd) is a dimeric lipocalin with a monomeric Mr
of 28 kDa [1,2]. The protein has three potential N-glycosyla-
tion sites namely Asn-28, Asn-63 and Asn-85 of which the ﬁrst
two are glycosylated [3]. The two main isoforms of Gd are
GdA (source: amniotic ﬂuid), which is synthesized by the glan-
dular epithelium of endometrium under the regulation of pro-
gesterone [4] and GdS (source: seminal plasma), synthesized by
the epithelium of seminal vesicles [5]. Both the isoforms are
products of the same gene but diﬀer in their glycan composi-
tion [6,7]. While glycans in glycodelin A (GdA) consist of sialy-
lated LacdiNac structures with terminal sialic acid residues,
GdS glycans are fucose and mannose rich [3,6].
One of the major functions of GdA is reported to be its
immunomodulatory activity. The protein has been docu-
mented to inhibit the proliferation of T and B-cells [8,9] and
the activity of NK cells [10]. Research from our laboratory
has shown unequivocally that GdA induces apoptosis in T-
cells [11] while GdS does not [12]. The immunomodulatory
activity of GdA has been implicated in the protection of the
fetus from the maternal immune attack.Abbreviations: DEAE, diethylaminoethyl; ELISA, enzyme-linked
immunosorbent assay; EtBr, ethidium bromide; Gd, Glycodelin;
GdA, glycodelin A; HRP, horse radish peroxidase; HSA, human
serum albumin; PBS, 50 mM phosphate buﬀer, 150 mM NaCl pH 7.2;
IPG strips, immobilized pH gradient strips
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doi:10.1016/j.febslet.2007.07.078One of the observations made in our laboratory is that GdA
puriﬁed from diﬀerent amniotic ﬂuid samples exhibit varying
degrees of activity with respect to induction of apoptosis in
T-cells. This led us to speculate that there could be subspecies
of GdA diﬀering in the activity. Using 2-D gel electrophoresis,
GdA could be seen to separate as closely spaced 3–4 spots [12]
conﬁrming that there are indeed more than one population of
GdA. Attempts were made to separate these forms and charac-
terize the same.2. Materials and methods
2.1. Puriﬁcation of GdA
Separation of subspecies of GdA. Pooled amniotic ﬂuid samples were
dialyzed against 2 mM phosphate buﬀer pH 7.2 and loaded on a dieth-
ylaminoethyl (DEAE) Sephacel column. Bound proteins were eluted
with 0.1 M NaCl followed by 0.3 M NaCl in the same buﬀer and frac-
tions were screened for the presence of GdA by Western blot analysis
with Gd speciﬁc mAb B1C2. The concentrations of GdA in 0.1 M and
0.3 M NaCl eluates were estimated using competitive enzyme-linked
immunosorbent assay (ELISA). The GdA containing fractions were
passed through a Gd speciﬁc mAb D9D4 aﬃnity column [12] pre-
equilibrated with 50 mM phosphate buﬀer, 150 mM NaCl pH 7.2
(PBS). The bound protein was eluted with 0.1 M glycine HCl, pH
2.5 and immediately neutralized with 1 M Tris pH 8. Presence of
GdA was detected by Western blot analysis.
2.2. Quantitation of GdA by ELISA
Gd (10 lg/ml in PBS) was coated in the wells of ELISA plate. Vary-
ing dilutions of the DEAE eluates of amniotic ﬂuid samples or stan-
dard GdA were incubated with mAb D9D4 (at a dilution of the
antibody exhibiting 80% of maximum binding) in the wells. The bind-
ing of the mAb to immobilized antigen was determined by subsequent
incubation with rabbit antibody to mouse Immunoglobulin (ramIg)
conjugated to horse radish peroxidase (HRP), followed by incubation
with the substrate, tetra methyl benzidine. After addition of 1 M
H2SO4, absorbance was measured at 450 nm in an ELISA reader.
The concentration of GdA was determined from the standard graph.
2.3. Jurkat cell proliferation assay [11]
Cells (0.1 · 106) were cultured in 200 ll of Roswell Park Memorial
Institute 1640 medium supplemented with 10% FBS (complete med-
ium), with GdA for 24 h followed by pulsing with [3H] thymidine for
6 h. The cells were harvested on glass ﬁbre ﬁlters and the incorporated
radioactivity was measured.
2.4. Quantitation of apoptosis
Jurkat cells (0.5 · 106) were cultured in 500 ll complete medium,
with GdA, for 18 h. The cells were harvested, washed and ﬁxed in
ice cold 70% ethanol overnight at 20 C, followed by incubation with
staining solution (50 lg/ml ethidium bromide (EtBr), 50 lg/ml RNase,
EDTA 100 lM dissolved in PBS) for 1 h. The samples were analyzed in
a ﬂuorescence activated cell scan (FACScan, BD Bioscience). The per-
centage of apoptotic cells was determined by measuring the sub G1
population [11].blished by Elsevier B.V. All rights reserved.
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agglutinin (SNA)
SNA was biotinylated using Sulfo-NHS biotin (Sigma, USA)
according to the manufacturer’s instructions. ELISA plates were
coated with varying concentrations of GdA in PBS, then incubated
with 15 lg/ml of SNA–biotin followed by incubation with streptavi-
din–HRP. The bound peroxidase activity was detected using as men-
tioned in Section 2.2.
2.6. Desialylation of glycans on GdA by neuraminidase treatment
Proteins (1 lg) in 100 mM acetate buﬀer pH 5.5 were incubated with
20 mU/ml of Vibrio cholerae neuraminidase (Sigma) at 37 C for 3 h,
then electrophoresed on a 12.5% polyacrylamide gel followed by trans-
fer to nitrocellulose membrane. The membrane was subjected to immu-
noblot analysis with mAb B1C2 and then developed using enhanced
chemiluminescence (Amersham Biosciences) according to manufac-
turer’s instructions.
2.7. Two-dimensional electrophoresis
Protein samples were precipitated with trichloroacetic acid and sol-
ubilized in the rehydration buﬀer (8 M urea, 2% 3-[(3-cholamidopro-
pyl)dimethylammonio]-1-propanesulfonate, 4–7 pH pharmalyte,
bromophenol blue). The immobiline IPG (immobilized pH gradient
strips) strips of pH 4–7 were rehydrated along with the samples for
14 h and were subjected to electrophoresis on a 1-D apparatus accord-
ing to the manufacturer’s instructions (Amersham Biosciences). The
strips were then treated with SDS equilibration buﬀer (50 mM Tris
HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, bromophenol blue)
along with 100 mg of DTT for 15 min, followed by treatment with
250 mg of iodoacetamide for 15 min The strip was overlaid on a
12.5% polyacrylamide gel, electrophoresed at 80 V, transferred to
nitrocellulose followed by and Western blot with mAb B1C2.Fig. 1. (a) Dialyzed amniotic ﬂuid was chromatographed on DEAE Sephac
(peak 2) Nacl. (b) The samples were electrophoresed on a 12.5% polyacrylami
immunoblot analysis with mAb B1C2. GdA was puriﬁed from the peak 1
proteins were subjected to electrophoresis followed by either (c) staining wit3. Results
All data presented are representative of at least 10 experi-
ments.
3.1. Puriﬁcation of GdA from amniotic ﬂuid
Amniotic ﬂuid samples were chromatographed on a DEAE
Sephacel column and elution was carried out using a NaCl gra-
dient of 0–0.5 M in phosphate buﬀer pH 7.2 of low ionic
strength. Western blot analyses of all fractions revealed that
there were mainly two populations of GdA, one which eluted
with 0.1 M NaCl and the other eluted with 0.3 M NaCl (data
not shown). Subsequently, the two populations of GdA were
eluted from the DEAE column with 0.1 M NaCl and 0.3 M
NaCl. Fig. 1a shows the elution proﬁle of the total protein
from the DEAE column. The protein containing fractions were
pooled and analyzed for the presence of GdA by Western blot-
ting with mAb B1C2 (Fig. 1b). These two populations were
subjected separately to immunoaﬃnity column chromatogra-
phy. The presence of GdA (GdA1, GdA2) was conﬁrmed by
Western blot analysis (Fig. 1d) and the purity was assessed
by silver staining (Fig. 1c).
In a separate experiment, GdA (GdA1 and GdA2) was puri-
ﬁed on immunoaﬃnity column, without subjecting to ion-ex-
change chromatography. The proportions of GdA1 and GdA2
in several independent amniotic ﬂuid samples were quantitated
by ELISA. The ratios of the same are presented in Table 1.el column. Bound proteins were eluted with 0.1 M (peak 1) and 0.3 M
de gel followed by transfer to nitrocellulose membrane and subjected to
and peak 2 pooled samples on immunoaﬃnity column. The puriﬁed
h silver nitrate or (d) Western blot analysis using mAb B1C2.
Table 1
Ratio of GdA1:GdA2 in the amniotic ﬂuid samples
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The diﬀerence in the net negative charge on the two popula-
tions was conﬁrmed by native gel electrophoresis. As is seen in
Fig. 2a, GdA2 (eluted with higher salt concentration) moves
faster than GdA1, indicating that GdA2 has a higher net neg-
ative charge than GdA1. The total GdA puriﬁed by aﬃnity
chromatography runs as a broad band encompassing the
mobilities of both GdA1 and GdA2 (Fig. 2a). The higher neg-
ative charge on GdA2 could be correlated to the presence of
more sialic acid residues as determined by binding to SNA
(Fig. 2c). On subjecting to 2-D electrophoresis, the pI range
for GdA2 was found to be 4.5–5.5, the major spot correspond-
ing to pI 4.9, and that for GdA1 was found to be 4.9–5.6, the
major spots corresponding to pI 5.2 and 5.4 (Fig. 2b), again
conﬁrming the more acidic nature of GdA2.
3.3. GdA2 but not GdA1 is inhibitory to T-cells
Puriﬁed GdA2 and total GdA inhibited Jurkat cell prolifer-
ation in a dose dependent manner (Fig. 3a). However, GdA1
exhibited no inhibitory activity on T-cells. The IC50 value of
GdA2 was 150 ng whereas that of the total GdA was
1.2 lg. In addition, only GdA2 induced apoptosis in Jurkat
cells (Fig. 3b and c).Fig. 2. (a) The proteins were electrophoresed on 12.5% polyacrylamide g
immunoblot analysis with mAb B1C2. The blot was then developed usin
immobiline IPG strips, pH 4–7, followed by electrophoresis on 12.5% polyacr
wells of ELISA plates, followed by incubation with biotinylated SNA. The3.4. Enzymatic desialylation of glycans on GdA reduces activity
GdA1, GdA2 and GdS were electrophoresed on a native gel
before and after neuraminidase treatment. It can be seen from
Fig. 4a that, while treatment with the enzyme had no eﬀect on
the mobility of GdA1 and as expected, on GdS, GdA2 showed
a distinct mobility shift, its mobility now comparable to that of
GdA1 and GdS. The 2-D proﬁle of GdA2 was also found to be
comparable to that of GdA1 (data not shown). The extent of
desialylation was conﬁrmed by solid phase assay using biotin-
ylated SNA (Fig. 4b). When tested in Jurkat cell proliferation
assay, the activity of GdA2 was markedly decreased after neur-
aminidase treatment (Fig. 4c). To negate the eﬀect of residual
neuraminidase on the cells, human serum albumin (HSA) trea-
ted with the enzyme was included as control.4. Discussion
GdA is a progesterone regulated [4] lipocalin that has been
documented to suppress the maternal immune response to
the fetal allo-antigens by inhibiting the proliferation of T-cells
[8] and induction of apoptosis [11]. It is known that though this
activity of GdA resides in the protein backbone [13] the gly-
cans regulate it [12,14], because while GdA exhibits immuno-
modulatory activity, the other main isoform, GdS with
diﬀerent glycan composition, is inactive. Relevant to this man-
uscript is our earlier observation that removal of sialic acid res-
idues from GdA decreases its activity [12]. More recently, two
more isoforms of Gd, diﬀering in glycan composition and
activity, namely GdF and GdC have been reported [15,16].
Analyses of the activity of GdA puriﬁed from several amni-
otic ﬂuid samples in our laboratory showed that the concentra-
tions required for inhibiting Jurkat cell proliferation diﬀered
considerably; the IC50 ranged from 100 ng to 1000 ng. We initi-
ated experiments ﬁrst to separate GdAmolecules based on their
net negative charge, presumably corresponding to the extent of
sialylation. Two populations of GdA could be identiﬁed by ion-el followed by transfer to nitrocellulose membrane and subjected to
g enhanced chemiluminescence. (b) The proteins were resolved on
ylamide gel and Western blot. (c) The proteins were immobilized in the
binding of the lectin was quantiﬁed by streptavidin–HRP. *P < 0.003.
Fig. 3. Jurkat cells (0.1 · 106) were cultured with varying concentrations of GdA, GdA1 or GdA2 for 24 h, following which the cells were either (a)
pulsed with [3H] thymidine for 6 h followed by harvesting on glass ﬁber ﬁlters, or, (b) the cells were ﬁxed in ethanol, stained with ethidium bromide
and the percentage of apoptotic population determined by FACS analysis; (c) histogram of the FACS proﬁle. GdBac: recombinant Gd expressed in
baculovirus expression system [13] was included as a positive control. The error bars indicate standard deviation. *P < 0.0006, **P < 0.0001.
Fig. 4. One microgram of GdA, GdA2, GdA1 and GdS were incubated without or with 20 mU/ml of neuraminidase for 3 h at 37 C; The proteins
were: (a) subjected to electrophoresis followed by Western blot analysis, (b) immobilized on ELISA plates, incubated with biotinylated SNA and the
binding quantiﬁed by streptavidin–HRP (asialofetuin (ASF) was taken as positive control), (c) the proteins were tested for their inhibitory activity on
Jurkat cells as described in the legend of Fig. 3a. GdBac was used as the positive control (UT – untreated, T – treated with neuraminidase). Control:
cells cultured with HSA treated with neuraminidase.
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(GdA1) and the other that eluted with 0.3 M NaCl (GdA2)
(Fig. 1). The diﬀerence in the net negative charge on the two
populations was determined by electrophoresis on native gel
(Fig. 2a) and that this diﬀerence could be attributed to the pres-
ence of higher or lower number of sialic acid residues was shown
by the direct binding to the sialic acid speciﬁc lectin SNA
(Fig. 2c). The charge diﬀerences on the two populations was fur-
ther conﬁrmed by 2-D gel electrophoresis; the pI of GdA1 was
found to range from 4.9 to 5.6, similar to the reported pI ofGdS [6] whereas the pI of GdA2 was found between 4.5 and
5.5 (Fig. 2b). Importantly, while GdA2 exhibited apoptotic
activity, GdA1 did not (Fig. 3b and c). More interesting was
the observation that GdA1 exhibited an electrophoretic mobil-
ity comparable to that of GdS as both these populations show
no apoptotic activity on Jurkat cells. On neuraminidase treat-
ment of GdA2, themobility of themolecule was the same as that
of GdA1 (Fig. 4a). In addition, the extent of sialylation of GdA2
after neuraminidase treatment was the same as that of GdA1
(Fig. 4b). This observation correlates well with the decrease in
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(Fig. 4c). The glycan composition of GdA has been character-
ized extensively. The complex type glycans that terminate in sia-
lic acid vary markedly from those that do not have sialic acid
residues [3]. More recently, and relevant to this study is the
report that GdA exhibit quantitative, physicochemical and
functional diﬀerences between diﬀerent individuals [17]. The
methodologies that we have adopted in this study however can-
not decipher the ﬁner diﬀerences in glycans. We have achieved
separation of GdA1 andGdA2 based only on the number of ter-
minal sialic acid residues on the glycans.
Little or no sialidase activity could be detectable in the sev-
eral amniotic ﬂuid samples tested in our laboratory (data not
shown), suggesting that the observations we have made with
respect to the two population of GdA are not artifactual.
It has been reported that plasma sialidase activity might reg-
ulate the activity of certain glycoprotein hormones like FSH,
LH, erythropoietin, etc. [18]. It is attractive to speculate that
GdA activity is also moderated by sialyl transferase and siali-
dase before secretion by the endometrium. When the require-
ment of the immunomodulatory activity is more, higher
levels of expression of the sialyl transferase may occur leading
to increased levels of GdA2 and therefore increased activity.
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